The Three Criteria for Radiological Response on Survival in Patients With Hepatocellular Carcinoma Treated With Lenvatinib

Hepatology Research - United Kingdom
doi 10.1111/hepr.13416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Impact of Adverse Events on the Progression-Free Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Lenvatinib: A Multicenter Retrospective Study

Drugs - Real World Outcomes
Pharmacology
2020English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

Phase 2 Study of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Journal of Gastroenterology
Gastroenterology
2016English

Carnitine Insufficiency Is Associated With Fatigue During Lenvatinib Treatment in Patients With Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2020English

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

Use of Initial Modified RECIST Tumor Response Evaluation Criteria for Predicting Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization With Drug-Eluting Beads

Journal of Cancer Therapy
2015English

Clusterin Role in Hepatocellular Carcinoma Patients Treated With Oxaliplatin

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

Evaluation of CT Vascularization Patterns for Survival Prognosis in Patients With Hepatocellular Carcinoma Treated by Conventional TACE

Diagnostic and Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2017English

Three Risk Factors for Pulmonary Metastasectomy in Patients With Hepatocellular Carcinoma

General Thoracic and Cardiovascular Surgery
CardiologyCardiovascular MedicineMedicineSurgeryRespiratory MedicinePulmonary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy